Resalis Therapeutics Reports Early Weight-Loss Signals in Phase 1a Trial of RES-010 for Obesity

The completed Phase 1a study data in healthy volunteers showed early signs of pharmacodynamic activity supporting further clinical evaluation of RES-010 T...

November 06, 2026 | Friday | News
MRM Health and Biocodex Partner on €15 Million Manufacturing Facility for Microbiome-Based Medicines

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration c...

November 06, 2026 | Friday | News
ArrayPatch Raises €3.2 Million in Seed Funding to Advance Microneedle Patch Treatments for Obesity and Cancer

ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, announced the successful completion of t...

November 06, 2026 | Friday | News
Ethris Reports 40-Fold Reduction in Viral Load in Phase 2a Trial of ETH47 for Asthma

40-fold lower virus load compared to placebo on Day 2, at the peak of viral replication Exposure-response relationship observed, with greater interferon l...

November 06, 2026 | Friday | News
Ambrose Healthcare’s Rare Disease Strategy: Reviving Promising Therapies Through Strategic Acquisitions

Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...

November 04, 2026 | Wednesday | Interview
Merck to Divest CDMO Business to Lonza to Sharpen Life Science Portfolio

Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck Transaction sharpens the focus of Merck&rsq...

November 04, 2026 | Wednesday | Analysis
HUTCHMED and AstraZeneca Secure Regulatory Review in Europe and Japan for ORPATHYS and TAGRISSO Lung Cancer Combination

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) announces that regulatory filings for ORPATHYS® (savolitinib) in combinati...

November 03, 2026 | Tuesday | News
Bracco Brings Together 14 Global Experts to Advance Contrast-Enhanced Ultrasound Research and Clinical Applications

Bracco convened the second edition of the Global CEUS Steering Committee, bringing together international experts in contrast-enhanced ultrasound (CEUS) to...

November 03, 2026 | Tuesday | News
Oculis Appoints Björn Tackenberg as Chief Scientific Officer and Aaron Tansy to Lead Neurology Development

Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the advanceme...

November 03, 2026 | Tuesday | News
Salvia Advances MySalvia Implantable Migraine Therapy with Pivotal RECLAIM-II Trial in the US

Biopharma Boardroom speaks with Hubert Martens, CEO of Salvia BioElectronics, about the development of the MySalvia System, an investigational implantable ...

November 02, 2026 | Monday | Interaction
Element Biosciences Launches AVITI Dx Sequencing Platform Across 10 European Markets

Element Biosciences, Inc. announced the commercial launch of AVITI Dx, the company's first CE-marked in vitro diagnostic (IVD) sequencing platform under th...

November 02, 2026 | Monday | News
Exogenus Therapeutics Leads €13 Million European Project to Advance EXO-101 for Osteoarthritis

ExoCordOA, a five-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clin...

October 30, 2026 | Friday | News
Philips Launches UniGuide 3D Live Guidance in Europe to Improve Precision in Image-Guided Procedures

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and a pioneer in image-guided therapy, announced the launch of Philips UniGuide...

October 30, 2026 | Friday | News
Axplora Advances Axotecan Development to Strengthen European Exatecan Supply for ADC Manufacturers

As demand for Exatecan-based antibody-drug conjugates (ADCs) grows, securing reliable manufacturing capacity and diversified supply chains has become a pri...

October 30, 2026 | Friday | Interaction

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close